Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services. The company also offers hospice services, including pain and symptom management, palliative and dietary counseling, social worker visits, spiritual counseling, and bereavement counseling services to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. As of March 31, 2022, it operated in 252 home health agencies and 99 hospice agencies across 34 states. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was incorporated in 2014 and is headquartered in Dallas, Texas. As of July 1, 2022, Enhabit, Inc. operates as a standalone company.
IPO Year: 2022
Exchange: NYSE
Website: https://www.ehab.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/9/2024 | $8.25 → $9.50 | Hold → Buy | Jefferies |
| 5/14/2024 | $8.50 | Underperform → Market Perform | Leerink Partners |
| 5/9/2024 | $14.00 → $8.75 | Buy → Hold | Jefferies |
| 3/7/2024 | $9.50 | Sell → Neutral | UBS |
| 12/12/2023 | $12.00 | Market Perform | TD Cowen |
| 6/20/2023 | $10.00 | Underperform | SVB Securities |
| 3/16/2023 | $15.00 | Neutral | Goldman |
| 12/13/2022 | $18.00 | Market Perform | CJS Securities |
| 12/8/2022 | $12.00 | Sell | UBS |
| 12/6/2022 | $17.00 | Buy | Stifel |
10-Q - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
PRE 14A - Enhabit, Inc. (0001803737) (Filer)
10-K/A - Enhabit, Inc. (0001803737) (Filer)
10-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
8-K - Enhabit, Inc. (0001803737) (Filer)
10-Q - Enhabit, Inc. (0001803737) (Filer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
4 - Enhabit, Inc. (0001803737) (Issuer)
Jefferies upgraded Enhabit Inc. from Hold to Buy and set a new price target of $9.50 from $8.25 previously
Leerink Partners upgraded Enhabit Inc. from Underperform to Market Perform and set a new price target of $8.50
Jefferies downgraded Enhabit Inc. from Buy to Hold and set a new price target of $8.75 from $14.00 previously
UBS upgraded Enhabit Inc. from Sell to Neutral and set a new price target of $9.50
TD Cowen initiated coverage of Enhabit Inc. with a rating of Market Perform and set a new price target of $12.00
SVB Securities initiated coverage of Enhabit Inc. with a rating of Underperform and set a new price target of $10.00
Goldman initiated coverage of Enhabit Inc. with a rating of Neutral and set a new price target of $15.00
CJS Securities initiated coverage of Enhabit Inc. with a rating of Market Perform and set a new price target of $18.00
UBS initiated coverage of Enhabit Inc. with a rating of Sell and set a new price target of $12.00
Stifel initiated coverage of Enhabit Inc. with a rating of Buy and set a new price target of $17.00
Company to host a conference call tomorrow, May 8, 2025, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2025. "Enhabit's first quarter 2025 results are a product of steadfast execution of our strategies," said Barb Jacobsmeyer, president and CEO of Enhabit. "Home health census grew 3.7% sequentially and hospice census grew 12.3% year over year. The combination of strong growth, improved profitability and continued balance sheet improvements resulted in a leverage ratio now below 4.5 times. This enables us to formally exit the covenant relief period restrictions in our
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2025, on May 7, 2025, and host a webcast and conference call on May 8, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. May 8, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast link: https://events.q4inc.com/attendee/885393432 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice Enhabit Home Hea
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced that it has achieved Level 2 recognition as an Age-Friendly Health System – Committed to Care Excellence by the Institute for Healthcare Improvement (IHI). This prestigious recognition honors Enhabit's dedication to providing high-quality, evidence-based care to older adults, ensuring their unique needs and preferences are consistently met. The Age-Friendly Health Systems initiative, led by The John A. Hartford Foundation and IHI in partnership with the American Hospital Association (AHA) and the Catholic Health Association of the United States (CHA), focuses on the 4Ms framework: What Matters, Medicatio
Company to host a conference call tomorrow, March 6, 2025, at 10 a.m. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2024. "Enhabit is exiting 2024 having executed specific strategies that set us up for long-term growth in both our home health and hospice segments," said Barb Jacobsmeyer, president and chief executive officer of Enhabit. "In our home health segment, fourth quarter Medicare census continued to stabilize, and with the renegotiation of a large national contract complete, we will be well positioned as a full-service provider to our referral sources. The hospice segm
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced its board of directors will nominate Stephan Rodgers to stand for election as a director of the company at Enhabit's 2025 annual meeting of stockholders. Chairman of the Board Jeff Bolton said, "We look forward to Steve joining us as a director and we believe our stockholders will agree that he brings strong, relevant industry expertise to our board. Steve's 25 years of executive-level experience in building companies of scale, including in the home health and hospice industry, will give him a unique perspective as our board oversees management's execution of our long-term strategies." Rodgers previou
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2024, on March 5, 2025, and host a webcast and conference call on March 6, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 6, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/519715442 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, announced today that it is proud to be Certified™ by Great Place To Work®. This prestigious award is based entirely on the experiences of current employees working at Enhabit. This year, 83% of employees said it's a great place to work, which is 26 points higher than the average U.S. company. Great Place To Work® is the global authority on workplace culture, employee experience and leadership behaviors proven to deliver market-leading revenue, employee retention and increased innovation. "Receiving the Great Place To Work Certification™ is a testament to the relentless hard work and dedication of our Enhabit team mem
On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit. The Court awarded judgment against private equity firms Vistria Group and Nautic Partners and the home health and hospice business now known as VitalCaring Group for aiding and abetting "the egregious breaches of the duty of loyalty" by Anthony, James, and Walker. The case was the subject of a 7-day trial in December 2023. After considering "the damning record presented at trial," the Court
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced its participation in the upcoming BofA Securities 2024 Home Care Conference. Enhabit's President and Chief Executive Officer Barb Jacobsmeyer, incoming Chief Financial Officer Ryan Solomon, and Senior Vice President of Strategic Finance & Treasurer Jobie Williams will participate in a fireside chat on Tuesday, Dec. 10, at 9:00 a.m. EST. The fireside chat will be webcast live and available for replay at https://investors.ehab.com under the events and presentations link. About Enhabit Home Health & Hospice Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice prov
Seasoned Industry Executive Brings Significant Financial Operations Expertise and Track Record of Driving Growth and Value Creation Enhabit, Inc. (NYSE:EHAB), ("Enhabit"), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon's appointment follows the previously announced transition of Crissy Carlisle, CFO. Mr. Solomon brings to Enhabit over 20 years of corporate strategy and finance experience, including eight years as CFO in the home health and hospice space and other industries. Mr. Solomon previously served as CFO of AccentCare, where he was responsible for financial pl
SC 13G - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
SC 13G/A - Enhabit, Inc. (0001803737) (Subject)
Company to host a conference call tomorrow, May 8, 2025, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2025. "Enhabit's first quarter 2025 results are a product of steadfast execution of our strategies," said Barb Jacobsmeyer, president and CEO of Enhabit. "Home health census grew 3.7% sequentially and hospice census grew 12.3% year over year. The combination of strong growth, improved profitability and continued balance sheet improvements resulted in a leverage ratio now below 4.5 times. This enables us to formally exit the covenant relief period restrictions in our
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2025, on May 7, 2025, and host a webcast and conference call on May 8, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. May 8, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast link: https://events.q4inc.com/attendee/885393432 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice Enhabit Home Hea
Company to host a conference call tomorrow, March 6, 2025, at 10 a.m. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2024. "Enhabit is exiting 2024 having executed specific strategies that set us up for long-term growth in both our home health and hospice segments," said Barb Jacobsmeyer, president and chief executive officer of Enhabit. "In our home health segment, fourth quarter Medicare census continued to stabilize, and with the renegotiation of a large national contract complete, we will be well positioned as a full-service provider to our referral sources. The hospice segm
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the fourth quarter ended Dec. 31, 2024, on March 5, 2025, and host a webcast and conference call on March 6, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. March 6, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/519715442 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice
Company to host a conference call tomorrow, November 7, 2024, at 10 a.m. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the third quarter ended September 30, 2024. "Our continued progress in our strategies during the third quarter resulted in Adjusted EBITDA growth year over year and strong free cash flow generation that led to further debt reduction," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "The payor innovation strategy continues to foster Medicare Advantage growth in our home health segment, and average daily census continues to grow in our hospice segment." QUARTERLY PERFORMAN
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the third quarter ended Sept. 30, 2024, on Nov. 6, 2024, and host a webcast and conference call on Nov. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Nov. 7, 2024 10 a.m. EST Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/164004764 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice Enhabit H
Enhabit, Inc. (NYSE:EHAB), ("Enhabit" or the "Company"), a leading home health and hospice care provider, today announced that Crissy Carlisle, chief financial officer, will step down from her role as CFO. Ms. Carlisle has agreed to facilitate a smooth transition of roles and responsibilities. Enhabit has initiated a comprehensive search to identify the Company's next chief financial officer. "Crissy has made important contributions to Enhabit since we became a public company just over two years ago," said Barb Jacobsmeyer, president and CEO of Enhabit. "Her deep commitment to our employees, patients, partners and stockholders, as well as her insights and financial acumen, have contribu
Company to host a conference call tomorrow, August 7, 2024, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the second quarter ended June 30, 2024. "The second quarter marked our third sequential quarter demonstrating the success of our strategies," said Enhabit's President and Chief Executive Officer Barb Jacobsmeyer. "In our home health segment, our total admissions growth of 6.4% was driven by our payor innovation strategy and our focus on improved utilization of our clinical resources. In our hospice segment, we continued to make steady progress in growing our census, with average daily census in
Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced certain unaudited preliminary results for the second quarter ended June 30, 2024. The Company plans to report actual second quarter 2024 financial results on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Unaudited Preliminary Results for the Second Quarter Ended June 30, 2024 Adjusted EBITDA* in the range of $24.5 million to $25.0 million Reduced bank debt by $15 million, including a $10 million payment on Enhabit's revolving credit facility 43% of Enhabit's non-Medicare visits shifting to payor innovation contracts at improved rates, an incr
Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the second quarter ended June 30, 2024, on Aug. 6, 2024, and host a webcast and conference call on Aug. 7, 2024. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. Aug. 7, 2024 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Internet website: https://events.q4inc.com/attendee/154318091 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice
On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit. The Court awarded judgment against private equity firms Vistria Group and Nautic Partners and the home health and hospice business now known as VitalCaring Group for aiding and abetting "the egregious breaches of the duty of loyalty" by Anthony, James, and Walker. The case was the subject of a 7-day trial in December 2023. After considering "the damning record presented at trial," the Court
Seasoned Industry Executive Brings Significant Financial Operations Expertise and Track Record of Driving Growth and Value Creation Enhabit, Inc. (NYSE:EHAB), ("Enhabit"), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon's appointment follows the previously announced transition of Crissy Carlisle, CFO. Mr. Solomon brings to Enhabit over 20 years of corporate strategy and finance experience, including eight years as CFO in the home health and hospice space and other industries. Mr. Solomon previously served as CFO of AccentCare, where he was responsible for financial pl
American Water Works Company, Inc. (NYSE:AWK) announced today that Stuart M. McGuigan has been appointed as an independent member of the company's board of directors, effective Oct. 29, 2024. "American Water is pleased to have Stuart join our board of directors," said Karl Kurz, Board Chair of American Water. "Stuart has more than 38 years of extensive experience in information technology and management including serving as the Chief Information Officer for national and global public companies, as well as a government agency. He will further strengthen our board, and we look forward to working with him." "We are honored to have Stuart become part of American Water's board," said M. Susan
NEW YORK, Sept. 6, 2024 /PRNewswire/ -- S&P Dow Jones Indices ("S&P DJI") will make the following changes to the S&P 500, S&P MidCap 400, and S&P SmallCap 600 indices effective prior to the open of trading on Monday, September 23, to coincide with the quarterly rebalance. The changes ensure each index is more representative of its market capitalization range. All companies being added to the S&P 500 are more representative of the large-cap market space, all companies being added to the S&P MidCap 400 are more representative of the mid-cap market space, and all companies being added to the S&P SmallCap 600 are more representative of the small-cap market space. The companies being removed from
Files Definitive Proxy Materials and Mails Letter to Stockholders AREX's Unqualified Slate of Nominees Risks Detracting from the Talent Currently on the Board Urges Stockholders to Vote "FOR" Only Enhabit's Nine Nominees on the YELLOW Proxy Card Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading home health and hospice provider, today announced that it has filed definitive proxy materials with the Securities and Exchange Commission in connection with its upcoming 2024 annual meeting of stockholders (the "2024 Annual Meeting") scheduled for July 25, 2024. Stockholders of record as of the close of business on June 5, 2024, are entitled to vote at the 2024 Annual Meeting.
Files Preliminary Proxy Statement; Elaborates on AREX Capital Management's Singular Focus in Demanding a Sale of the Company Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company") today announced that it has filed its preliminary proxy materials with the Securities and Exchange Commission (the "SEC") in connection with its upcoming 2024 annual meeting of stockholders (the "2024 Annual Meeting"). The preliminary proxy statement is available on the Investor Relations section of the Enhabit website at investors.ehab.com. The Company is filing a preliminary proxy statement because AREX Capital Management, LP (together with its affiliates and associates, "AREX") has notified the Company that
Board Appointments Support the Company's Previously Announced Board Transition Plan Enhabit, Inc. (NYSE:EHAB) ("Enhabit" or the "Company"), a leading national home health and hospice provider, today announced an agreement with Cruiser Capital Advisors LLC ("Cruiser") and Harbour Point Capital Management LP ("Harbour Point" ), which collectively own approximately 4.7% of the outstanding shares of Enhabit's common stock, pursuant to which Enhabit has appointed Stuart McGuigan and Barry Schochet to its board of directors, effective immediately. With these appointments the Company's board will expand temporarily to 13 directors. As Enhabit previously disclosed in May 2022 ahead of the complet
Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice provider, today announced the appointment of Dylan Black as general counsel, effective January 2023. "We are excited to welcome Dylan to the Enhabit team," Enhabit President and CEO Barb Jacobsmeyer said. "He has served as a trusted legal advisor to many organizations, and we look forward to the leadership and contributions he will bring to Enhabit." Black brings more than 24 years of legal experience helping publicly traded companies. Most recently, Black served as a partner at Bradley Arant Boult Cummings LLP where he represented companies across various industries including health care, banking and environmental services. In